| Description: Highly crystalline homopolymer phase, very high molecular weight ERP phase, very high flexural modulus, reduced emissions, reduced gels. Applications: Suggested uses include compounding. Process: Compounding This resin meets the requirements for olefin polymers as defined in 21 CFR, section 177.1520 issued by the Food and Drug Administration. The additives present are covered in appropriate regulation by FDA. Information provided by Braskem |
